89 related articles for article (PubMed ID: 15574559)
21. Aprotinin reduces the need for blood products during liver transplantation.
Scudamore CH; Randall TE; Jewesson PJ; Shackleton CR; Salvian AJ; Fagan M; Frighetto L; Growe GH; Scarth I; Erb SR
Am J Surg; 1995 May; 169(5):546-9. PubMed ID: 7538269
[TBL] [Abstract][Full Text] [Related]
22. [Liver transplantation: the problem of peroperative bleeding].
Roseau E
Presse Med; 2000 Jul; 29(23):1289-90. PubMed ID: 10923137
[No Abstract] [Full Text] [Related]
23. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study.
Dalmau A; Sabaté A; Koo M; Bartolomé C; Rafecas A; Figueras J; Jaurrieta E
Liver Transpl; 2004 Feb; 10(2):279-84. PubMed ID: 14762867
[TBL] [Abstract][Full Text] [Related]
24. Pro: Antifibrinolytics are safe and effective in patients undergoing liver transplantation.
Lerner AB
J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):888-90. PubMed ID: 17138101
[No Abstract] [Full Text] [Related]
25. Role of leukocytes in hemostasis during orthotopic liver transplantation.
Riess H; Jochum M; Machleidt W; Himmelreich G; Bechstein WO; Muser M; Neuhaus P; Roissant R; Huhn D
Semin Thromb Hemost; 1993; 19(3):197-208. PubMed ID: 7689749
[No Abstract] [Full Text] [Related]
26. Con: Antifibrinolytics are not safe and effective in patients undergoing liver transplantation.
Ramsay MA
J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):891-3. PubMed ID: 17138102
[No Abstract] [Full Text] [Related]
27. Effectiveness of aprotinin in orthotopic liver transplantation.
Suárez M; Sangro B; Herrero JI; Picardi A; Páramo JA; Quiroga J; Pardo F; Cienfuegos J; Carrera J; Hidalgo F
Semin Thromb Hemost; 1993; 19(3):292-6. PubMed ID: 7689754
[No Abstract] [Full Text] [Related]
28. Postoperative aprotinin: effect on blood loss and transfusion requirements in cardiac operations.
Ciçek S; Demirkiliç U; Kuralay E; Ozal E; Tatar H
Ann Thorac Surg; 1996 May; 61(5):1372-6. PubMed ID: 8633944
[TBL] [Abstract][Full Text] [Related]
29. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
Lindvall G; Sartipy U; van der Linden J
Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
[TBL] [Abstract][Full Text] [Related]
30. Aprotinin (Trasylol) does not reduce bleeding in primary total hip arthroplasty.
Langdown AJ; Field J; Grote J; Himayat H
J Arthroplasty; 2000 Dec; 15(8):1009-12. PubMed ID: 11112196
[TBL] [Abstract][Full Text] [Related]
31. Defining the role of aprotinin in heart transplantation.
Prendergast TW; Furukawa S; Beyer AJ; Eisen HJ; McClurken JB; Jeevanandam V
Ann Thorac Surg; 1996 Sep; 62(3):670-4. PubMed ID: 8783991
[TBL] [Abstract][Full Text] [Related]
32. Aprotinin: safe and effective in all patients undergoing orthotopic liver transplantation?
Porte RJ; Slooff MJ
Liver Transpl; 2001 Sep; 7(9):808-10. PubMed ID: 11552216
[No Abstract] [Full Text] [Related]
33. Current methods to reduce the adverse haematological consequences of cardiopulmonary bypass.
John LC; Deverall PB
Br J Clin Pract; 1996 Jun; 50(4):203-6. PubMed ID: 8759566
[TBL] [Abstract][Full Text] [Related]
34. Antifibrinolytics do not reduce transfusion requirements in patients undergoing orthotopic liver transplantation.
Kufner RP
Liver Transpl Surg; 1997 Nov; 3(6):668-74; discussion 674-6. PubMed ID: 9404975
[No Abstract] [Full Text] [Related]
35. Acute plateletpheresis and aprotinin reduces the need for blood transfusion following Ross operation.
Al-Rashidi F; Bhat M; Pierre L; Koul B
Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):618-22. PubMed ID: 17670731
[TBL] [Abstract][Full Text] [Related]
36. The effect of aprotinin on transfusion requirements in pediatric orthotopic liver transplantation.
Rentoul TM; Harrison VL; Shun A
Pediatr Transplant; 2003 Apr; 7(2):142-8. PubMed ID: 12654056
[TBL] [Abstract][Full Text] [Related]
37. Predictors of blood product use in orthotopic liver transplantation using the piggyback hepatectomy technique.
Mangus RS; Kinsella SB; Nobari MM; Fridell JA; Vianna RM; Ward ES; Nobari R; Tector AJ
Transplant Proc; 2007 Dec; 39(10):3207-13. PubMed ID: 18089355
[TBL] [Abstract][Full Text] [Related]
38. Randomized study of aprotinin effect on transfusions and blood loss in primary THA.
Colwell CW; Chelly JE; Murkin JM; Stevens D; O'Keefe TJ; Hall R; Parvizi J
Clin Orthop Relat Res; 2007 Dec; 465():189-95. PubMed ID: 17767075
[TBL] [Abstract][Full Text] [Related]
39. Decreasing use of donated blood and reduction of bleeding after orthotopic heart transplantation by use of aprotinin.
Havel M; Owen AN; Simon P; Teufelsbauer H; Zwoelfer W; Laczkovics A; Wolner E
J Heart Lung Transplant; 1992; 11(2 Pt 1):348-9. PubMed ID: 1374266
[TBL] [Abstract][Full Text] [Related]
40. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
